Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
Sponsor: Nishtar Medical University
Summary
This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.
Official title: Comparison of Intralesional Triamcinolone and Intralesional Verapamil in the Treatment of Keloids
Key Details
Gender
All
Age Range
10 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-04-01
Completion Date
2025-09-30
Last Updated
2025-04-01
Healthy Volunteers
No
Conditions
Interventions
Triamcinolone Acetonide 1 ml of 40 mg/mL suspension
Monthly intralesional injection
Verapamil Injection
2.5 mg of intralesional Verapamil injection monthly
Locations (1)
Nishtar Medical University & Hospital
Multan, Punjab Province, Pakistan